This is a video showing the MOA of thrombin inhibition on intracranial haemorrhage. It shows how dabigatran, a thrombin inhibitor minimises thrombin mediated damage and preserves the brain barrier, thereby minimising intracranial hemorage. It showcases the RE-LY trial as well as the confirmation of the trial by RWE.
Dabigatran, a direct thrombin inhibitor, reduces the risk of an intracerebral haemorrhage: Protection of the blood brain barrier
October 1, 2019
Keep up to date with our latest
articles and journals